CLL highlights from EHA and ICML: the CLL-12 study

2 Views

07/08/23

In this video, Barbara Eichhorst, MD , University of Cologne, Cologne, Germany, shares her chronic lymphocytic leukemia (CLL) highlights from this year’s EHA and ICML conferences, discussing the Phase III placebo-controlled, double-blind CLL-12 study (NCT02863718). This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.